Proteomics Solutions for Drugging the Undruggable
Evotecs's Industrial-Scale Mass Spectrometry-based Proteomics
Evotec's expertise in industrial-scale mass spectrometry-based proteomics is revolutionizing drug discovery. Our advanced workflows and instrumentation enable comprehensive proteome-scale profiling. This supports the discovery of drugs targeting previously undruggable proteins. Our ScreenPep™ platform delivers high-throughput, ultra-deep proteomics profiling with precision, analyzing up to 300,000 samples annually.
These innovations in proteomics are transforming pharmaceutical and biotech industries by enabling the development of molecular glues, targeted protein degraders, stabilizers, and covalent ligands.
Download the white paper now to embark on a journey into the fascinating world of omics and revolutionize your approach to drug discovery.
